Editas Medicine (EDIT) Accumulated Expenses (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Accumulated Expenses data on file, last reported at $32.6 million in Q4 2025.

• Accumulated Expenses for Q4 2025 came in at $32.6 million, down 28.89% year-over-year; the trailing twelve-month figure through Dec 2025 was $32.6 million (down 28.89% YoY), and the FY2025 annual result was $32.6 million, down 28.89% from the prior year.
• Accumulated Expenses retreated to $32.6 million in Q4 2025 per EDIT's latest filing, from $47.5 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $48.1 million in Q2 2025 and troughed at $4.4 million in Q1 2021.
• A 5-year average of $23.9 million and a median of $28.2 million in 2024 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2021 and 2024: Accumulated Expenses plunged 52.53% in 2021, then surged 428.56% in 2024.
• A 5-year view of Accumulated Expenses shows it stood at $10.2 million in 2021, then surged by 208.06% to $31.3 million in 2022, then climbed by 10.44% to $34.6 million in 2023, then jumped by 32.68% to $45.9 million in 2024, then dropped by 28.89% to $32.6 million in 2025.
• Business Quant data shows EDIT's Accumulated Expenses at $32.6 million in Q4 2025, $47.5 million in Q3 2025, and $48.1 million in Q2 2025.